Literature DB >> 29897225

Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.

Dianjun Qi1, Shaohua Wu2, Haishuang Lin3, Mitchell A Kuss, Yuguo Lei3, Alexey Krasnoslobodtsev4, Shaheen Ahmed, Chi Zhang, Hyung Joon Kim, Peng Jiang5, Bin Duan.   

Abstract

The blood-brain barrier (BBB) is an active and complex diffusion barrier that separates the circulating blood from the brain and extracellular fluid, regulates nutrient transportation, and provides protection against various toxic compounds and pathogens. Creating an in vitro microphysiological BBB system, particularly with relevant human cell types, will significantly facilitate the research of neuropharmaceutical drug delivery, screening, and transport, as well as improve our understanding of pathologies that are due to BBB damage. Currently, most of the in vitro BBB models are generated by culturing rodent astrocytes and endothelial cells, using commercially available transwell membranes. Those membranes are made of plastic biopolymers that are nonbiodegradable, porous, and stiff. In addition, distinct from rodent astrocytes, human astrocytes possess unique cell complexity and physiology, which are among the few characteristics that differentiate human brains from rodent brains. In this study, we established a novel human BBB microphysiologocal system, consisting of a three-dimensionally printed holder with a electrospun poly(lactic- co-glycolic) acid (PLGA) nanofibrous mesh, a bilayer coculture of human astrocytes, and endothelial cells, derived from human induced pluripotent stem cells (hiPSCs), on the electrospun PLGA mesh. This human BBB model achieved significant barrier integrity with tight junction protein expression, an effective permeability to sodium fluorescein, and higher transendothelial electrical resistance (TEER) comparing to electrospun mesh-based counterparts. Moreover, the coculture of hiPSC-derived astrocytes and endothielial cells promoted the tight junction protein expression and the TEER value. We further verified the barrier functions of our BBB model with antibrain tumor drugs (paclitaxel and bortezomib) and a neurotoxic peptide (amyloid β 1-42). The human microphysiological system generated in this study will potentially provide a new, powerful tool for research on human BBB physiology and pathology.

Entities:  

Keywords:  3D printing; drug screening; electrospinning; human induced pluripotent stem cells; transepithelial electrical resistance

Mesh:

Substances:

Year:  2018        PMID: 29897225      PMCID: PMC6052796          DOI: 10.1021/acsami.8b03962

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  67 in total

1.  Molecular structure and function of the tight junction. Proceedings of an international conference dedicated to the memory of Shoichiro Tsukita. April 25-27, 2008. Berlin, Germany.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

2.  Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models.

Authors:  Kathryn Hatherell; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Geoffrey J Pilkington
Journal:  J Neurosci Methods       Date:  2011-05-14       Impact factor: 2.390

Review 3.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 4.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

6.  A novel electrospun biphasic scaffold provides optimal three-dimensional topography for in vitro co-culture of airway epithelial and fibroblast cells.

Authors:  G E Morris; J C Bridge; L A Brace; A J Knox; J W Aylott; C E Brightling; A M Ghaemmaghami; F R A J Rose
Journal:  Biofabrication       Date:  2014-06-13       Impact factor: 9.954

7.  Melanoma cells homing to the brain: an in vitro model.

Authors:  A Rizzo; C Vasco; V Girgenti; V Fugnanesi; C Calatozzolo; A Canazza; A Salmaggi; L Rivoltini; M Morbin; E Ciusani
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

8.  Gene Expression Changes in Long-Term In Vitro Human Blood-Brain Barrier Models and Their Dependence on a Transwell Scaffold Material.

Authors:  Joel D Gaston; Lauren L Bischel; Lisa A Fitzgerald; Kathleen D Cusick; Bradley R Ringeisen; Russell K Pirlo
Journal:  J Healthc Eng       Date:  2017-11-29       Impact factor: 2.682

9.  A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells.

Authors:  Adjanie Patabendige; Robert A Skinner; Louise Morgan; N Joan Abbott
Journal:  Brain Res       Date:  2013-04-17       Impact factor: 3.252

Review 10.  Traversing the basement membrane in vivo: a diversity of strategies.

Authors:  Laura C Kelley; Lauren L Lohmer; Elliott J Hagedorn; David R Sherwood
Journal:  J Cell Biol       Date:  2014-02-03       Impact factor: 10.539

View more
  17 in total

Review 1.  Human-Derived Organ-on-a-Chip for Personalized Drug Development.

Authors:  Yasamin A Jodat; Min G Kang; Kiavash Kiaee; Gyeong J Kim; Angel F H Martinez; Aliza Rosenkranz; Hojae Bae; Su R Shin
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

2.  A Hybrid Nanofiber/Paper Cell Culture Platform for Building a 3D Blood-brain Barrier Model.

Authors:  Kaixiang Huang; Andre Castiaux; Ram Podicheti; Douglas B Rusch; R Scott Martin; Lane A Baker
Journal:  Small Methods       Date:  2021-08-16

Review 3.  Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.

Authors:  Weisen Zhang; Ami Mehta; Ziqiu Tong; Lars Esser; Nicolas H Voelcker
Journal:  Adv Sci (Weinh)       Date:  2021-03-07       Impact factor: 16.806

4.  Design and Evaluation of an In Vitro Mild Traumatic Brain Injury Modeling System Using 3D Printed Mini Impact Device on the 3D Cultured Human iPSC Derived Neural Progenitor Cells.

Authors:  Wen Shi; Pengfei Dong; Mitchell A Kuss; Linxia Gu; Forrest Kievit; Hyung Joon Kim; Bin Duan
Journal:  Adv Healthc Mater       Date:  2021-04-23       Impact factor: 11.092

Review 5.  Studying Heterotypic Cell⁻Cell Interactions in the Human Brain Using Pluripotent Stem Cell Models for Neurodegeneration.

Authors:  Liqing Song; Yuanwei Yan; Mark Marzano; Yan Li
Journal:  Cells       Date:  2019-04-01       Impact factor: 6.600

6.  Concise Review: Harnessing iPSC-derived Cells for Ischemic Heart Disease Treatment.

Authors:  Bin Duan
Journal:  J Transl Int Med       Date:  2020-05-09

Review 7.  In Vitro Blood-Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device.

Authors:  Jin-Ha Choi; Mallesh Santhosh; Jeong-Woo Choi
Journal:  Micromachines (Basel)       Date:  2019-12-24       Impact factor: 2.891

Review 8.  Electrospun Fiber Scaffolds for Engineering Glial Cell Behavior to Promote Neural Regeneration.

Authors:  Devan L Puhl; Jessica L Funnell; Derek W Nelson; Manoj K Gottipati; Ryan J Gilbert
Journal:  Bioengineering (Basel)       Date:  2020-12-29

Review 9.  Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases.

Authors:  Xingchi Chen; Chang Liu; Laureana Muok; Changchun Zeng; Yan Li
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

10.  A collagen gel-coated, aligned nanofiber membrane for enhanced endothelial barrier function.

Authors:  Dohui Kim; Seongsu Eom; Sang Min Park; Hyeonjun Hong; Dong Sung Kim
Journal:  Sci Rep       Date:  2019-10-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.